Anawin (2.5+8) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Neon Laboratories Ltd. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Sodium Chloride, Bupivacaine. This drug comes in the form of Injection. The general packing available for this medicine consists of 20 ml and is priced at Rs 54 (arround $0.756 US Dollar)
Generic (Salt) Combination :
(Sodium Chloride+ Bupivacaine)
Pharma Company :
Neon Laboratories Ltd
Brand Label :
Anawin (2.5+8)
Preparation Type :
Injection
Single Dose :
1 ml
Composition (Fixed-Dose Combination) :
Sodium Chloride-8 mg
Bupivacaine-2.5 mg
Pack Size/Qty/Vol :
20 ml
Price Unit :
Rs 2.7 INR (arround $0.0378 US Dollar)
Price Pack :
Rs 54 INR (arround $0.756 US Dollar)
Drug details for Anawin (2.5+8)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Anawin (2.5+8) are :
Sodium Chloride-8 mg
Bupivacaine-2.5 mg
Sodium Chloride Indication (Prescribed for or used as): Hyponatraemia. Electrolite imbalance. Hypovolumic shock.
For more details on Sodium Chloride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Sodium Chloride..
Bupivacaine Indication (Prescribed for or used as): Infiltration, block, caudal, epidural, lumbor, anaesthesia with long duration of action.
For more details on Bupivacaine, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Bupivacaine..
Anawin (2.5+8) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Anawin (2.5+8), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Sodium Chloride-8 mg Bupivacaine-2.5 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.